PRESERFLO™ MicroShunt as a treatment option for highly increased intraocular pressure in primary open angle glaucoma and pseudoexfoliation glaucoma.

ABSTRACT:

Purpose

The Preserflo-MicroShunt (PF) is an established device for treating glaucoma, effectively reducing intraocular pressure (IOP) with a good safety record. However, its efficacy in eyes with significantly elevated preoperative IOP levels is not well-documented due to exclusion from many clinical studies. This study aims to evaluate PF outcomes in eyes with highly increased IOP and compare them with those having moderately increased levels.

Methods

Retrospectively, eyes diagnosed with primary open angle glaucoma (POAG) or pseudoexfoliation glaucoma (PXG) undergoing PF were analysed. They were categorized into two groups: highly increased IOP (HI-IOP, ≥30 mmHg) and moderately increased IOP (MI-IOP, ≤25 mmHg). IOP, number of IOP lowering medications (NoM), success rates (S

SUBMITTER: Theilig T 

PROVIDER: S-EPMC12274334 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature